|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-16
|
|
pubmed:abstractText |
To evaluate the off-treatment durability of response in HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined 'Response' (HBV-DNA<0.7MEq/mL and ALT<1.25xULN) with entecavir at 48 weeks and the efficacy of entecavir in patients treated beyond one year.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:Brett-SmithHelenaH,
pubmed-author:CarosiGiampieroG,
pubmed-author:ChangTing-TsungTT,
pubmed-author:CheinquerHugoH,
pubmed-author:HanStevenS,
pubmed-author:KaymakogluSabahattinS,
pubmed-author:LaiChing-LungCL,
pubmed-author:MartinPaulP,
pubmed-author:ShouvalDanielD,
pubmed-author:TamezRicardoR,
pubmed-author:TenneyDanielD,
pubmed-author:YangJoannaJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-95
|
|
pubmed:meshHeading |
pubmed-meshheading:19070393-Alanine Transaminase,
pubmed-meshheading:19070393-Antiviral Agents,
pubmed-meshheading:19070393-DNA, Viral,
pubmed-meshheading:19070393-Double-Blind Method,
pubmed-meshheading:19070393-Drug Resistance, Viral,
pubmed-meshheading:19070393-Guanine,
pubmed-meshheading:19070393-Hepatitis B, Chronic,
pubmed-meshheading:19070393-Hepatitis B e Antigens,
pubmed-meshheading:19070393-Humans,
pubmed-meshheading:19070393-Lamivudine,
pubmed-meshheading:19070393-Recurrence,
pubmed-meshheading:19070393-Viral Load
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
|
|
pubmed:affiliation |
Liver Unit, Hadassah - Hebrew University Hospital, Ein-Kerem, Jerusalem 91120, Israel. shouval@cc.huji.ac.il
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Multicenter Study
|
